SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

Atara Biotherapeutics Earlier Reported Q3 EPS $(1.31) Beats $(1.44) Estimate

Atara Biotherapeutics (NASDAQ:ATRA) reported quarterly losses of $(1.31) per share which beat the analyst consensus estimate of $(1.44) by 9.03 percent. This is a 1.55 percent decrease over losses of $(1.29) per share

Benzinga · -

Atara Biotherapeutics (NASDAQ:ATRA) reported quarterly losses of $(1.31) per share which beat the analyst consensus estimate of $(1.44) by 9.03 percent. This is a 1.55 percent decrease over losses of $(1.29) per share from the same period last year.